Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet’s disease

Medicine and Dentistry

• Apremilast 100%
• Mouth Ulcer 91%
• Genital Ulcer 83%
• Patient 83%
• Diseases 75%
• Pain 33%
• Randomized Clinical Trial 33%
• Adverse Event 25%
• Visual Analog Scale 25%
• Venous Ulcer 25%
• Combination Therapy 16%
• Therapeutic Procedure 16%
• Relapse 16%
• Follow up 8%
• Biological Product 8%
• Informed Consent 8%
• Disease Activity 8%
• Life 8%
• Evaluation Study 8%
• Student T Test 8%
• Statistical Analysis 8%
• Paracetamol 8%
• Disease Duration 8%
• Diarrhea 8%
• Immunosuppressive Drug 8%
• Tertiary Care 8%
• Wilcoxon Signed Ranks Test 8%
• Off-Label Use 8%
• Selection Bias 8%
• Phosphodiesterase IV Inhibitor 8%
• Hospital 8%
• Observation 8%
• Joint 8%
• Quality of Life 8%
• Female 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Apremilast 100%
• Mouth Ulcer 91%
• Genital Ulcer 83%
• Diseases 75%
• Pain 33%
• Adverse Event 25%
• Ulcer 25%
• Relapse 16%
• Case Report 16%
• Biological Product 8%
• Diarrhea 8%
• Immunosuppressive Agent 8%
• Disease Activity 8%
• Paracetamol 8%
• Disease Duration 8%
• Phosphodiesterase IV Inhibitor 8%
• Off-Label Use 8%
• Symptom 8%